Inhibition of transforming growth factor alpha stimulation of human squamous cell carcinoma of the head and neck with anti-TGF-α antibodies and tyrphostin

Annals of Surgical Oncology

Volumn 4, Issue 8, 1997, Pages 670-684

  Solorzano, Carmen C ^b   Jones, Shawn C ^a   Pettitjean, Mark ^d   O'Daniel, Thomas G ^a   Auffenberg, Troy ^b   Woost, Philip G ^a   Copeland III, Edward M ^b   Moldawer, Lyle L ^b   Schultz, Gregory S ^c   MacKay, Sally L D ^b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d NONE

Author keywords

Anti TGF antibodies; EGF receptors; TGF ; Tyrphostin

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; HEAD AND NECK TUMOR; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA;

AUTOCRINE COMMUNICATION; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; HEAD AND NECK NEOPLASMS; HUMANS; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; REGRESSION ANALYSIS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

EID: 0031304175     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303753     Document Type: Article

References (51)

1. The epidermal growth factor family. In: Carpenter G, Wahl MI, Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors. New York: Springer-Verlag, 1991:69-171.
2. Derynck R. Transforming growth factor alpha. Cell 1988;54: 593-5.
3. MacKay SLD, Bennett NT, Bland KI, Schultz GS. Growth factors, tumor suppressors, and cancer. Perspectives in General Surgery 1992;3:1-25.
4. Barrandon Y, Green H. Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor. Cell 1987;50:1131-7.
5. Coffey RJ Jr, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, Pittelkow MR. Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature 1987; 328:817-20.
6. Schultz GS, White M, Mitchell R, Brown G, Lynch J, Twardzik DR, Todaro GJ. Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science 1987; 235:350-2.
7. Nanney LB, Magid M, Stoscheck CM, King LE. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol 1984;83:385-93.
8. Damjanov I, Mildner B, Knowles BB. Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues. Lab Invest 1986;55:588-92.
9. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990;61:1121-35.
10. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 1993;73:249-61.
11. Luetteke NC, Phillips HK, Qiu TH, Copeland NG, Earp HS, Jenkins NA, Lee DC. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 1994;8:399-413.
12. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 1993;73:263-78.
13. Mydlo JH, Michaeli J, Cordon Cardo C, Goldenberg AS, Heston WD, Fair WR. Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res 1989;49: 3407-11.
14. Damstrup L, Rygaard K, Spang Thomsen M, Poulsen HS. Expression of the epidermal growth factor receptor in human small cell lung cancer cell lines. Cancer Res 1992;52:3089-93.
15. Veale D, Kerr N, Gibson GJ, Harris AL. Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Cancer Res 1989;49:1313-7.
16. Veale D, Kerr N, Gibson GJ, Kelly PJ, Harris AL. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br J Cancer 1993; 68:162-5.
17. Mellon JK, Cook S, Chambers P, Neal DE. Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor. Br J Cancer 1996;73:654-8.
18. Rajkumar T, Gullick WJ. The type I growth factor receptors in human breast cancer. Breast Cancer Res Treat 1994;29:3-9.
19. Lemoine NR, Hughes CM, Barton CM, et al. The epidermal growth factor receptor in human pancreatic cancer. J Pathol 1992; 166:7-12.
20. Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L, Waterfield MD. Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res 1986; 46:285-92.
21. Modjtahedi H, Dean C. The receptor for EGF and its ligands: expression, prognostic value and target for therapy in cancer (review). Int J Oncol 1994;4:277-96.
22. Partridge M, Green MR, Langdon JD, Feldmann M. Production of TGF-alpha and TGF-beta by cultured keratinocytes, skin and oral squamous cell carcinomas - potential autocrine regulation of normal and malignant epithelial cell proliferation. Br J Cancer 1989; 60:542-8.
23. Todd R, Donoff BR, Gertz R, et al. TGF-alpha and EGF-receptor mRNAs in human oral cancers. Carcinogenesis 1989;10:1553-6.
24. Yoshida K, Kyo E, Tsuda T, Tsujino T, Ito M, Niimoto M, Tahara E. EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors. Int J Cancer 1990;45:131-5.
25. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993;53:3579-84.
26. Christensen ME, Therkildsen MH, Poulsen SS, Bretlau P. Transforming growth factor alpha and epidermal growth factor in laryngeal carcinomas demonstrated by immunohistochemistry. Acta Otolaryngol Stockh 1993;113:563-7.
27. Christensen ME, Therkildsen MH, Poulsen SS, Bretlau P. Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas. J Pathol 1993;169:323-8.
28. Christensen ME, Therkildsen MH, Hansen BL, Hansen GN, Bretlau P. Immunohistochemical detection of epidermal growth factor receptor in laryngeal squamous cell carcinomas. Acta Otolaryngol Stockh 1992;112:734-8.
29. Christensen ME, Therkildsen MH, Hansen BL, Albeck H, Hansen GN, Bretlau P. Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas. Eur Arch Otorhinolaryngol 1992;249:243-7.
30. Reiss M, Stash EB, Vellucci VF, Zhou ZL. Activation of the autocrine transforming growth factor alpha pathway in human squamous carcinoma cells [published erratum appears in Cancer Res 1992;52:6137]. Cancer Res 1991;51:6254-62.
31. Divgi CR, Welt S, Kris M, et al. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma [see comments]. J Natl Cancer Inst 1991;83:97-104.
32. Eccles SA, Modjtahedi H, Box G, Court W, Sandle J, Dean CJ. Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy. Invasion Metastasis 1994;14:337-48.
33. Siegall CB, Xu YH, Chaudhary VK, Adhya S, Fitzgerald D, Pastan I. Cytotoxic activities of a fusion protein comprised of TGF alpha and Pseudomonas exotoxin. FASEB J 1989;3:2647-52.
34. Modjtahedi H, Eccles S, Sandle J, Box G, Titley J, Dean C. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. Cancer Res 1994;54:1695-701.
35. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995:267:1782-8.
36. Osherov N, Levitzki A. Epidermal-growth-factor-dependent activation of the Src-family kinases. Eur J Biochem 1994;225:1047-53.
37. Schultz GS, Twardzick DR. Assessment of biological activity of synthetic fragments of TGF-α. In: Barnes D, Mather JP, Sato GH, eds. Methods in Enzymology. New York: Academic Press, 1991:200-13.
38. Fitzpatrick SL, LaChance MP, Schultz GS. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res 1984;44:3442-7.
39. Giugni TD, James LC, Haigler HT. Epidermal growth factor stimulates tyrosine phosphorylation of specific proteins in permeabilized human fibroblasts. J Biol Chem 1985;260:15081-90.
40. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
41. Kovalenko M, Gazit A, Bohmer A, et al. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res 1994;54:6106-14.
42. Yagisawa M, Yuo A, Kitagawa S, Yazaki Y, Togawa A, Takaku F. Stimulation and priming of human neutrophils by IL-α and IL-1β: Complete inhibition by IL-1 receptor antagonist and no interaction with other cytokines. Exp Hematol 1995;23:603-8.
43. Perroteau I, Salomon D, DeBortoli M, et al. Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells. Breast Cancer Res Treat 1986;7:201-10.
44. Hansen K, Moller JV. Application of two-dimensional gel analysis to identification and characterization of tyrosine phosphorylated substrates for growth factor receptors. Electrophoresis 1993;14: 112-26.
45. Barnes JA, Michiel D, Hollenberg MD. Simultaneous phosphorylation of three human calpactins by kinase. Biochem Cell Biol 1991;69:163-9.
46. Mokashi S, Severson DL, Hollenberg MD. Synergistic actions of epidermal growth factor-urogastrone and vasopressin in cultured aortic A-10 smooth muscle cells. J Cell Physiol 1992;152:372-81.
47. Prime SS, Game SM, Matthews JB, et al. Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines. Br J Cancer 1994;69:8-15.
48. Modjtahedi H, Eccles SA, Box G, Styles J, Dean CJ. Antitumor activity of combinations of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor. Cell Biophys 1993;22:129-46.
49. Baselga J, Mendelsohn J, Kim Y-M, Pandiella A. Autocrine regulation of membrane transforming growth factor-α cleavage. J Biol Chem 1996;271:3279-84.
50. Modjtahedi H, Hickish T, Nicolson M, et al. Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer. Br J Cancer 1996;73:228-35.
51. Modjtahedi H, Dean C. The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists. Biochem Biophys Res Commun 1995;207:389-97.